- Home
- BBNX
as of 12-05-2025 3:46pm EST
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 1.2B | IPO Year: | 2025 |
| Target Price: | $28.09 | AVG Volume (30 days): | 618.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.50 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.89 - $32.71 | Next Earning Date: | 10-28-2025 |
| Revenue: | $88,570,000 | Revenue Growth: | 67.01% |
| Revenue Growth (this year): | 52.13% | Revenue Growth (next year): | 36.16% |
AI-Powered BBNX Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare BBNX vs Leading Stocks
See how BBNX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "BBNX Beta Bionics Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.